Product Information
METHYLPHENIDATE ER(LA) 30 MG CP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $2.0321 per EA under NDC 00093534701. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
30 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093534701
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA079031On Market Since
7/16/2012
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE ER(LA) 30 MG CP has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 52.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0321 per EA |
|---|---|
| All-time high | $5.0876 (Sep 14, 2016) |
| All-time low | $1.0799 (May 19, 2021) |
| 52-week high | $2.9073 |
| 52-week low | $2.0321 |
| Median price | $3.3453 |
| Average price | $3.1351 |
| Largest weekly change | +71.5% (Aug 23, 2023) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE ER(LA) 30 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER(LA) 30 MG CP, manufactured by Teva Pharmaceuticals USA Inc., is $2.0321 per EA (NDC 00093534701), effective Jun 24, 2026.
How has the price of METHYLPHENIDATE ER(LA) 30 MG CP changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE ER(LA) 30 MG CP has declined 52.9%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER(LA) 30 MG CP?
Since Nov 28, 2013, the NADAC for METHYLPHENIDATE ER(LA) 30 MG CP has ranged from a low of $1.0799 (May 19, 2021) to a high of $5.0876 (Sep 14, 2016), with a median of $3.3453 per EA.
Are there cheaper alternatives to METHYLPHENIDATE ER(LA) 30 MG CP?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METHYLPHENIDATE ER(CD) 30 MG CP, is $1.8150 per EA — about 11% below METHYLPHENIDATE ER(LA) 30 MG CP.
Who manufactures METHYLPHENIDATE ER(LA) 30 MG CP?
METHYLPHENIDATE ER(LA) 30 MG CP (NDC 00093534701) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification